News & Events


  • January 17, 2017
    Posted by: Joe Martinez, RPh, PDE, PPC

    We’ve all been there before if you’ve been doing clinical trials for some time: the protocol is approved, patients are recruited and enrolled, clinical sites engage and monitor their patients and then the happy day of the last patient visit. However, don’t pop the bubbly just yet because the database needs to be locked and […]

  • January 10, 2017
    Posted by: Joe Martinez, RPh, PDE, PPC

    Clinical trials are more complex, more involved and span the globe. Clinical trials involve people, patients, stakeholders, researchers, administrators, and regulators, to name just a few. Next: add on training, monitoring and oversight to provide quality data in a short time-frame and you have a recipe for disaster! What’s a poor boy (or girl) to […]

  • January 3, 2017
    Posted by: Jamie Zacher, PharmD

    In clinical trials, sponsor companies are trying to prove that their therapy is effective and safe for patients to use. A critical component of the clinical trial is the patient. Recruitment and enrollment is a top priority for all clinical trials because without volunteers, there is no data to show that a therapy is safe […]

  • December 20, 2016
    Posted by: Jamie Zacher, PharmD

    The goal in any clinical trial is to test a drug or therapy to find out what the benefits and risks are to the patient, and if that therapy should ultimately be made available to the general public. In order for this to happen, the Sponsor Company, clinical investigators and clinicians need accurate, unbiased and […]

  • December 13, 2016
    Posted by: Joe Martinez, RPh, PDE, PPC

    Now, I don’t have anything personal against Vampires and some of my favorite horror movies growing up were with the blood-stained eyes of Dracula peering over his silky, black cape and uttering those famous words, “I vant, to suck your blood…” However, having Vampires in clinical trials is a real drain.  Especially when the ‘blood’ […]

  • November 29, 2016
    Posted by: John Moore, Executive Chairman, Trialogics

    Whether it is Uber’s upending of transport or Airbnb’s disruption of the lodging industry, upstarts are combining technology and business models in new ways to change our world.  This is also true in the healthcare industry which has recently introduced the concept of the virtual or in-home clinical trial and ‘site-less’ clinical trial research organization. […]

  • November 22, 2016
    Posted by: Joe Martinez, RPh, PDE, PPC

    Clinical trials cost time, effort and resources to design, recruit, enroll and manage patients through a new therapy.  Health outcomes are collected, compiled and analyzed with much sweat and tears as well as the hope of securing successful and meaningful results. If the drug or device doesn’t meet the expectation of the study, it could […]

  • November 15, 2016
    Posted by: Jamie Zacher, PharmD

    Prescription drug spending in the United States in 2015 was estimated to be about $457 billion according to a report from the Department of Health and Human Services.  Specialty drugs account for around 30% of this total.[1] This report also indicates that spending on specialty drugs appears to be rising more rapidly than spending on […]

  • November 8, 2016
    Posted by: Jamie Zacher, PharmD

    A personal health record (PHR) is used by patients to collect, maintain, and share all current and past medical information. This is in comparison to a medical health record which is owned and maintained by a health care system, institution or government payer. Let’s look at how a patient may determine if an ePHR is […]

  • November 1, 2016
    Posted by: Jamie Zacher, PharmD

    A medical record is not the same as a Personal Health Record (PHR). A medical record is information maintained by a healthcare provider and a PHR is information maintained by the patient. Patients own their PHR while the healthcare provider or payer owns the medical record that contains their medical information. However, according to the […]

  • Case Study
    A Biopharmaceutical Company Sponsoring a Phase III Clinical Trial in the U.S.
  • Latest News
    Center Point Clinical Services Names Gerald E. Finken New CEO
    March 15, 2018
  • Need More Information?